Literature DB >> 23583118

Haloperidol for treatment of cannabinoid hyperemesis syndrome.

Jami L Hickey1, Joanne C Witsil, Mark B Mycyk.   

Abstract

Cannabinoid hyperemesis syndrome (CHS) is a condition characterized by cyclical vomiting without other identifiable cause in patients with chronic cannabis use. Patients with CHS report that compulsive bathing and hot showers are the only reliable treatments to improve symptoms. Cannabinoid hyperemesis syndrome is usually unresponsive to conventional pharmacologic antiemetics, and patients often require hospital admission. We report a case of CHS that improved significantly after treatment with haloperidol in the emergency department.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583118     DOI: 10.1016/j.ajem.2013.02.021

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  15 in total

1.  Management of Pediatric Cannabinoid Hyperemesis Syndrome: A Review.

Authors:  Justin P Reinert; O'Neill Niyamugabo; Kiersi S Harmon; Norman E Fenn
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19

2.  A case of cannabinoid hyperemesis syndrome highlighting related key paediatric issues.

Authors:  Cameron F Leveille; Robert M Issenman; April J Kam
Journal:  Paediatr Child Health       Date:  2020-06-15       Impact factor: 2.253

3.  In Response to Letter to the Editor Regarding: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2017-03-10

4.  Colorado Cannabis Legalization and Its Effect on Emergency Care.

Authors:  Howard S Kim; Andrew A Monte
Journal:  Ann Emerg Med       Date:  2016-02-24       Impact factor: 5.721

5.  A hot mess: a case of hyperemesis.

Authors:  Eileen Cheung; Carly Ng; John Foote
Journal:  Can Fam Physician       Date:  2014-07       Impact factor: 3.275

6.  Intravenous haloperidol for the treatment of intractable vomiting, cyclical vomiting, and gastroparesis.

Authors:  Brad E Schwartz; Karen Keller Baker; Andrew J Bleinberger; Amina Lleshi; Raul Cruz-Cano
Journal:  World J Emerg Med       Date:  2021

Review 7.  Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2016-12-20

8.  Cannabinoid hyperemesis syndrome.

Authors:  Jai D Parekh; Susan E Wozniak; Kamran Khan; Sudhir K Dutta
Journal:  BMJ Case Rep       Date:  2016-01-20

9.  Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using Haloperidol in the Outpatient Setting.

Authors:  Jennifer L Jones; Karen E Abernathy
Journal:  Case Rep Psychiatry       Date:  2016-08-11

10.  Characterizing the role of haloperidol for analgesia in the Emergency Department.

Authors:  Matt Cowling; Stephen Covington; Christian Roehmer; Paul Musey
Journal:  J Pain Manag       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.